Cell death and birth in multiple sclerosis brain

Journal of the Neurological Sciences
P DowlingM Sidhu

Abstract

The hallmark of the brain pathology in multiple sclerosis is the white matter plaque, characterized by myelin destruction and oligodendrocyte loss. To examine the role that cell death plays in the development of MS lesions, we used the in situ TUNEL technique, a method that sensitively detects DNA fragmentation associated with death at the single cell level. We found that patchy areas within acute MS lesions have massive numbers of inflammatory and glial cells undergoing cell death. The punched out areas of some long-standing chronic lesions also had labeled glial cells showing that the attack was not a single event. Immunocytochemical identification of the dying cells with glial specific marker co-labeling showed that 14-40% were the myelin-sustaining oligodendroglial cell. Confocal microscopic evaluation of fluorescein-labeled TUNEL positive cells revealed nuclei with morphologic characteristics of apoptosis, and electrophoresed MS brain DNA produced a ladder characteristic of apoptotic DNA cleavage confirming that substantial numbers of labeled cells, but not necessarily all, were dying by apoptotic mechanisms rather than cell necrosis. Companion studies using a marker for cell proliferation on MS lesions revealed that unexp...Continue Reading

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Oct 11, 1992·Nucleic Acids Research·F Rösl
Jul 1, 1991·Journal of the Neurological Sciences·M P PenderJ F Kerr
Mar 1, 1991·The Journal of Clinical Investigation·K SelmajC F Brosnan
Dec 1, 1990·Histopathology·D C Brown, K C Gatter
Apr 1, 1988·Annals of Neurology·K W Selmaj, C S Raine
Sep 1, 1986·The Journal of General Virology·P C DowlingS D Cook
Jun 14, 1967·Journal of Molecular Biology·B Hirt
May 1, 1983·Journal of Neuropathology and Experimental Neurology·H M Wisniewski, R E Madrid
Jun 1, 1995·Neuropathology and Applied Neurobiology·H A GelbardL G Epstein
Jun 1, 1995·Neuropathology and Applied Neurobiology·H Adle-BiassetteF Gray
Nov 1, 1995·Journal of Neuropathology and Experimental Neurology·C K Petito, B Roberts
May 1, 1995·Trends in Biochemical Sciences·S Kumar
Apr 1, 1995·Current Opinion in Cell Biology·J Yuan
Jun 1, 1995·Journal of Internal Medicine·S Orrenius
Dec 1, 1994·Brain : a Journal of Neurology·K OzawaH Lassmann
Jun 1, 1994·Neuropathology and Applied Neurobiology·C S MorrisN Gregson
May 1, 1994·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·K FehselV Kolb-Bachofen
Jan 1, 1994·Annals of Neurology·W BrückH Lassmann
Jul 1, 1993·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R GoldH Lassmann
Oct 1, 1996·The Journal of Experimental Medicine·P DowlingW Husar

❮ Previous
Next ❯

Citations

Dec 8, 1998·Journal of Neuroscience Research·T AndrewsN R Bhat
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Arundhati Jana, Kalipada Pahan
Jan 31, 2004·Neurobiology of Disease·Charles L HoweMoses Rodriguez
May 9, 2002·Journal of the Neurological Sciences·Xue MingPeter C Dowling
Apr 30, 1998·Journal of the Neurological Sciences·A MénardF Rieger
Jan 8, 1999·Journal of the Neurological Sciences·G ContiG Scarlato
Nov 24, 1999·Journal of the Neurological Sciences·T FukazawaK Tashiro
Jul 30, 1999·Journal of Neuroimmunology·B D TrappA Chang
Mar 1, 2000·Journal of Neuroimmunology·K A Sabelko-DownesA H Cross
Feb 23, 2000·Journal of Neuroimmunology·A AlcázarJ C Alvarez-Cermeño
Jul 23, 2003·Neuroscience Research·Shin HisaharaMasayuki Miura
Jul 3, 2003·Molecular and Cellular Neurosciences·Christopher B McBrideJohn D Steeves
May 12, 2001·Cell Proliferation·F MicoudC Malcus-Vocanson
Oct 17, 1998·Neuropathology and Applied Neurobiology·L M SchönrockW Brück
Jan 13, 2000·Neuropathology and Applied Neurobiology·J E Merrill, N J Scolding
May 20, 1998·Proceedings of the National Academy of Sciences of the United States of America·D C ShieldsN L Banik
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·D C HooperH Koprowski
Jan 4, 2001·The Journal of Experimental Medicine·S HisaharaM Miura
Dec 10, 1999·Annals of the New York Academy of Sciences·G ContiG Scarlato
Jan 17, 2004·Clinical Microbiology Reviews·Emilia L OleszakChris D Platsoucas
Dec 19, 2013·Journal of Neuroinflammation·Mahdia BenkhouchaPatrice H Lalive
Mar 29, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jie GaoCe Yang
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Laura CalzaLuciana Giardino
Sep 2, 2014·Brain Pathology·Alison Ruth Jennings, William M Carroll
Jul 21, 2009·Journal of the Neurological Sciences·John A Lincoln, Stuart D Cook
May 12, 2007·Journal of Neuroimmunology·Bernadette KalmanSamuel Komoly
Dec 10, 2003·British Journal of Pharmacology·Mirna Marques BezerraFrancisco Airton Castro da Rocha
Mar 30, 2004·Annals of Neurology·Michael H Barnett, John W Prineas
Nov 1, 2008·The European Journal of Neuroscience·Yoshio BandoShigetaka Yoshida
Nov 12, 2005·Neuropathology and Applied Neurobiology·J C V M CoprayH W G M Boddeke
Jul 26, 2012·Annals of Neurology·John W Prineas, John D E Parratt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.